The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
Abstract
The development of new blood vessels (angiogenesis) is required for many physiological processes including embryogenesis, wound healing and corpus luteum formation. Blood vessel neoformation is also important in the pathogenesis of many disorders, particularly rapid growth and metastasis of solid tumours. There are several potential mediators of tumour angiogenesis, including basic and acidic fibroblast growth factors, tumour necrosis factor-alpha and transforming factors-alpha and -beta. But it is unclear whether any of these agents actually mediates angiogenesis and tumour growth in vivo. Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen and an angiogenesis inducer released by a variety of tumour cells and expressed in human tumours in situ. To test whether VEGF may be a tumour angiogenesis factor in vivo, we injected human rhabdomyosarcoma, glioblastoma multiforme or leiomyosarcoma cell lines into nude mice. We report here that treatment with a monoclonal antibody specific for VEGF inhibited the growth of the tumours, but had no effect on the growth rate of the tumour cells in vitro. The density of vessels was decreased in the antibody-treated tumours. These findings demonstrate that inhibition of the action of an angiogenic factor spontaneously produced by tumour cells may suppress tumour growth in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In 1993, it was reported that treatment with anti‐VEGF monoclonal antibodies resulted in a significant reduction in vessel density and a significant delay in tumor growth in nude mice carrying rhabdomyosarcoma, glioblastoma multiforme (GBM), and leiomyosarcoma xenografts.”
From Hypoxia signaling in cancer: Implications for therapeutic interventions (2023) · cites this paper as [266]
Citations
Cites
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,598
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 5,000
Self-citationVascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,509
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,651
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,269
Self-citationPlate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,262
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
Keck, P. J., Hauser, S. D., Krivi, G. G., Sanzo, K., Warren, T. G., Feder, J., & Connolly, D. T. (1989) · Science · doi:10.1126/science.2479987 · Cited by 2,058
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,988
Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins
Ferrara, N., Houck, K. A., Jakeman, L. B., & LEUNG, D. W. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-18 · Cited by 1,655
Self-citationHouck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B., & Leung, D. W. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-1806 · Cited by 1,364
Self-citationSynthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
Ingber, D. E., Fujita, T., KISHIMOTO, S., Sudo, K., KANAMARU, T., Brem, H., & Folkman, J. (1990) · Nature · doi:10.1038/348555a0 · Cited by 1,301
Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., & Ferrara, N. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35712-0 · Cited by 1,127
Self-citationBreier, G., Albrecht, U., Sterrer, S., & Risau, W. (1992) · Development · doi:10.1242/dev.114.2.521 · Cited by 1,087
Klagsbrun, M., & D'Amore, P. A. (1991) · Annual Review of Physiology · doi:10.1146/annurev.ph.53.030191.001245 · Cited by 983
Berse, B., Brown, L. F., Water, L. V. D., Dvorak, H. F., & Senger, D. R. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.2.211 · Cited by 897
Senger, D. R., Perruzzi, C. A., Feder, J., & Dvorak, H. F. (1986) · PubMed · Cited by 646
Plouët, J., Schilling, J., & Gospodarowicz, D. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08557.x · Cited by 502
Berkman, R. A., Merrill, M. J., Reinhold, W. C., Monacci, W. T., Saxena, A., Clark, W. C., Robertson, J. T., Ali, I. U., & Oldfield, E. H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116165 · Cited by 462
Jakeman, L. B., Winer, J., Bennett, G. L., Altar, C. A., & Ferrara, N. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115568 · Cited by 433
Self-citationConn, G., BAYNE, M. L., Soderman, D. D., Kwok, P., Sullivan, K. A., Palisi, T. M., Hope, D. A., & Thomas, K. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2628 · Cited by 357
Kim, K. J., Li, B., Houck, K. A., Winer, J., & Ferrara, N. (1992) · Growth Factors · doi:10.3109/08977199209023937 · Cited by 306
Self-citationHuman Vascular Permeability Factor
Connolly, D. T., Olander, J. V., Heuvelman, D. M., Nelson, R. M., Monsell, R., Siegel, N. R., Haymore, B. L., Leimgruber, R. M., & Feder, J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47212-8 · Cited by 291
Vascular Endothelial Growth Factor is Expressed in Rat Corpus Luteum
PHILLIPS, H. S., Hains, J. M., LEUNG, D. W., & Ferrara, N. (1990) · Endocrinology · doi:10.1210/endo-127-2-965 · Cited by 277
Self-citationVascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary
Ravindranath, N., LITTLE-IHRIG, L. L., PHILLIPS, H. S., Ferrara, N., & Zeleznik, A. J. (1992) · Endocrinology · doi:10.1210/endo.131.1.1612003 · Cited by 265
Self-citationFerrara, N., Winer, J., Burton, T., Rowland, A. M., Siegel, M., PHILLIPS, H. S., Terrell, T., Keller, G. A., & Levinson, A. D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116166 · Cited by 163
Self-citationSchweigerer, L., Neufeld, G., Mergia, A., Abraham, J. A., Fiddes, J. C., & Gospodarowicz, D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.3.842 · Cited by 150
An angiogenic growth factor is expressed in human glioma cells.
Libermann, T. A., Friesel, R. E., Jaye, M., Lyall, R. M., Westermark, B., Drohan, W. N., Schmidt, A., Maciag, T., & Schlessinger, J. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02410.x · Cited by 148
Conditioned Medium from Mouse Sarcoma 180 Cells Contains Vascular Endothelial Growth Factor
Rosenthal, R. A., Megyesi, J. F., Henzel, W. J., Ferrara, N., & Folkman, J. (1990) · Growth Factors · doi:10.3109/08977199009011010 · Cited by 100
Self-citation[32] Soft agar growth assays for transforming growth factors and mitogenic peptides
Rizzino, A. (1987) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(87)46035-7 · Cited by 48
Berman, P. W., Riddle, L. M., Nakamura, G. R., Haffar, O. K., Nunes, W. M., Skehel, P., Byrn, R. A., Groopman, J. E., Matthews, T. J., & Gregory, T. J. (1989) · Journal of Virology · doi:10.1128/jvi.63.8.3489-3498.1989 · Cited by 42
Flagged first, then by citations
1 of the 32 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Senger, D., Perruzzi, C. A., Feder, J. & Dvorak, H. F. Cancer Res. 46, 5629 (1986).
- Westphal, M. et al. Expl cell. Biol. 55, 152–161 (1987).
Cited by
Sorted by citations
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Self-citationThe biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Self-citationPaclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Sandler, A., Gray, R., Perry, M. C., Brahmer, J., Schiller, J. H., Dowlati, A., Lilenbaum, R., & Johnson, D. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061884 · Cited by 5,761
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Metadata
- Authors
- Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N.
- Affiliations
- Genentech (US)
- Venue
- Nature
- Published
- 1993-04
- Volume
- 362
- Issue
- 6423
- Pages
- 841-844
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1969328947
- Cited by
- 3,605
- References
- 32
- Citations by year
- 2026: 22 · 2025: 25 · 2024: 43 · 2023: 47 · 2022: 53 · 2021: 55 · 2020: 55 · 2019: 54 · 2018: 89 · 2017: 101 · 2016: 81 · 2015: 78 · 2014: 98 · 2013: 110 · 2012: 137
- FWCI
- 32.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- vascular endothelial growth factor, angiogenesis, tumor angiogenesis, tumor growth inhibition, monoclonal antibodies, rhabdomyosarcoma, glioblastoma, leiomyosarcoma, tumor vasculature, nude mice, tumour metastasis
- MeSH terms
- Animals, Antibodies, Monoclonal, Cell Division, Female, Glioblastoma, Humans, Leiomyosarcoma, Lymphokines, Mice, Nude, Neoplasm Transplantation, Neoplasms, Experimental, Neovascularization, Pathologic, Rhabdomyosarcoma, Tumor Cells, Cultured, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
